Point-of-Care Ultrasound (POCUS): Uses, Devices & Training

Point-of-care ultrasound changed one thing above all: who holds the probe. Not a sonographer working from a request, but the clinician treating the patient — at the bedside, answering one question at a time. Here is what it answers, what the evidence supports, what the hardware costs, and where the limits sit.

Written and clinically reviewed by
Fernando Mariz, MD · Gynecology, pelvic surgery, sonography
Jailyn Avila, MD · Emergency medicine, POCUS education
Verified authors
Updated July 25, 2026

Every clinical statement below is attributed to a named medical society, federal agency, health system, or peer-reviewed study; device and regulatory history is attributed to the maker’s own announcement or to the FDA; and every current price traces to the manufacturer’s own page, with third-party and historical figures labelled where they appear, on the access dates listed in Sources.

The whole topic, in one table

POCUS at a glance

Sources with URLs and access dates are listed in full at the end of this page. Society definitions describe POCUS as an examination and practice pattern; patient-facing and search language often stretches “POCUS ultrasound” to mean the portable device itself. This page uses the society meaning throughout.

Fifteen questions, one at a time

What POCUS is used for, application by application

Emergency medicine has the most formally defined application set, so it is the clearest place to see what “focused” means in practice. ACEP’s 2023 guidelines name 15 core emergency ultrasound applications, selected on criteria the document states directly: “widespread use, significant evidence base, uniqueness in diagnosis or decision-making, importance in primary emergency diagnosis and patient care, or technological advance.” Two of the 15 are procedural; the other 13 are diagnostic. The 2016 edition listed 12 — testicular imaging and ultrasound-guided nerve blocks were added, and soft tissue was split from musculoskeletal.

Application names quoted verbatim from ACEP, Ultrasound Guidelines: Emergency, Point-of-care, and Clinical Ultrasound Guidelines in Medicine, revised April 2023. The questions in the right-hand column describe what each application is used to ask; they are not statements of diagnostic accuracy. Accuracy figures, with their sources, are in the evidence section below.

How it got here

Four decades in eleven steps

POCUS did not arrive with the pocket probe. The practice pattern — clinician scans, clinician interprets, decision follows immediately — was built over forty years of protocols, curricula, and credentialing fights. The hardware caught up last.

The boundary that matters

POCUS and comprehensive ultrasound: complement, not substitute

This is the distinction that gets blurred most often, and the societies are not vague about it. WFUMB’s position paper states that point-of-care ultrasound “is not a replacement for comprehensive ultrasound.” ACEP defines emergency ultrasound as ultrasound “performed and interpreted by the provider as an emergency procedure and directly integrated into the care of the patient,” and contrasts it with consultative ultrasound — the study you request, for which the patient travels to an imaging department and a consultant returns an interpretation. AIUM makes the same point inside obstetrics: a limited obstetric examination is “a focused obstetrical ultrasound examination performed to answer a specific clinical question or concern,” which is a different thing from the standard diagnostic examination defined jointly by AIUM, ACR, ACOG, SMFM and SRU.

Built from WFUMB’s 2017 position paper, ACEP’s ultrasound guideline definitions, and AIUM’s statement on limited obstetric examinations. Full citations in Sources.

A focused exam answers one question. It is not a smaller version of the complete study.

What the literature actually reports

The evidence, in plain language

Every number in this section belongs to a specific study, in a specific population, performed by the operators that study enrolled. None of it is a claim about any particular device, and none of it transfers automatically to a different setting or a less-trained scanner. Read them as what they are: the reasons these applications became standard practice. Two of the documents behind this section define scope rather than accuracy: the American Society of Echocardiography’s 2013 focused cardiac ultrasound consensus and the Society of Critical Care Medicine’s 2015 and 2016 bedside-ultrasonography guidelines set out what a focused cardiac or ICU examination covers — a different question from how often it is right.

Detecting pneumothorax after trauma

A 2020 Cochrane review of chest ultrasonography performed by frontline non-radiologist physicians reported pooled sensitivity of 0.91 (95% CI 0.85–0.94) and specificity of 0.99 (0.97–1.00) for traumatic pneumothorax, against supine chest radiography at sensitivity 0.47 (0.31–0.63) and specificity 1.00 — a sensitivity difference of 0.44 (P < 0.001). Nine studies and 1,271 patients contributed to the primary analysis.

Finding the cause of acute respiratory failure

The BLUE protocol study reported that lung ultrasound provided an immediate diagnosis of the cause of acute respiratory failure in 90.5% of 260 dyspneic patients admitted to intensive care who had a definite final diagnosis (Lichtenstein and Mezière, Chest, 2008).

Time to the operating room in torso trauma

The SOAP-1 randomized controlled trial reported that point-of-care limited ultrasonography for suspected torso trauma reduced time from emergency department arrival to operative care by 64% (95% CI 48–76) compared with usual care, across 262 patients enrolled at two Level I trauma centers (Melniker et al., Annals of Emergency Medicine, 2006).

Guided vascular access

A 2015 Cochrane review of real-time two-dimensional ultrasound guidance for internal jugular vein catheterization, compared with anatomical landmarks, reported a 71% reduction in total complications (RR 0.29, 95% CI 0.17–0.52; 14 trials, 2,406 participants), a 72% reduction in inadvertent arterial puncture (RR 0.28, 0.18–0.44; 22 trials, 4,388 participants), a 73% reduction in haematoma (RR 0.27, 0.13–0.55), and a 57% increase in first-attempt success (RR 1.57, 1.36–1.82). In the reviewers’ words, “two-dimensional ultrasound offers gains in safety and quality when compared with an anatomical landmark technique.”

Peripheral nerve blocks

A Cochrane review updated in 2015 (32 studies, 2,844 participants) reported that the evidence suggests ultrasound guidance for upper- and lower-limb peripheral nerve blocks is superior to other nerve-location techniques such as neurostimulation and landmark approaches — with the reviewers’ own caveat preserved: the effect of practitioner experience is unclear.

Generalist and primary-care use

A 2019 systematic review in The Ultrasound Journal (19 articles on extent of use, plus 26 meta-analyses and 168 primary studies) found that generalist POCUS use among general practitioners is “variable, but generally low,” while studies generally showed high sensitivity or high specificity for the particular focused test being studied. Its authors concluded that generalists “can, given a certain level of pre-test probability, safely use PoCUS in a wide range of clinical settings to aid diagnosis.”

Bladder volume, both sides of it

Portable bladder-scanner measurements of post-void residual have been reported to correlate strongly with catheterized volume — correlation coefficients around 0.93 to 0.95 in several studies — and a prospective equivalence study after vaginal delivery concluded that automatic scanning devices “can prevent unnecessary catheterizations,” with potential reductions in nosocomial infection, discomfort and cost. The same literature also reports systematic underestimation of volume in some populations, beyond a 30 mL mean-absolute-error threshold. Both findings are on the record, in different populations.

System-level effects, stated as the guideline states them

ACEP’s policy language is careful, and worth keeping intact: clinical ultrasound “may provide significant benefits by reducing the needs for hospitalization, improved diagnosis and improved outcomes.” One study also reports POCUS being associated with improved patient satisfaction and perceived care efficiency in hospital settings — single-centre evidence, and best read as suggestive rather than settled.

Right internal carotid artery · power Doppler · 10.0 MHz · 40 mm depth · captured 2026-04-10

Right kidney · B-mode, convex · 5.0 MHz · 160 mm depth · captured 2025-10-19

Vena cava · B-mode, convex · 3.2 MHz · 160 mm depth · captured 2025-10-19

The hardware, without a ranking

POCUS devices: the three classes, and what they cost

“POCUS machine” is a search term, not a product category. Three hardware classes are in current clinical use, and the choice between them is a workflow decision rather than a quality ladder.

1. Cart and console systems. Full-size platforms wheeled to the bedside. The most capable and the least mobile; they cost substantially more than the handheld class, and are the machines POCUS grew up beside rather than replaced.
2. Laptop and tablet portables. A middle class with an attached screen and a carrying handle — the format that made bedside scanning practical before phones were good enough to be the display.
3. Handheld and pocket probes. The transducer is the machine; a phone or tablet is the screen. This class splits two ways: probes wired to the display device (Butterfly, Philips Lumify) and fully wireless probes (GE Vscan Air, Clarius, Suresult, and Mindray’s TE Air, which Mindray’s own product page titles a “Wireless Handheld Ultrasound System” — brand depth in the Mindray price guide). EchoNous’s Kosmos sits in the same handheld class, presented on EchoNous’s own site as an ultraportable handheld point-of-care device.

Prices verified on manufacturers’ own pages, July 25, 2026

Brand & device	Class	Software model	Price — as of Jul 25, 2026
Butterfly iQ3 & iQ+wired to phone/tablet	Handheld, wired	Membership tiers: Core $299/yr or Advanced $420/yr; a one-time Advanced option at $1,500 with software access guaranteed for five years and no recurring fees required	$3,899 iQ3 (3-yr warranty) $2,699 iQ+ (1-yr warranty)
Clarius HD3 rangewireless, per-specialty probes	Handheld, wireless	Each scanner listed as including one year of the Clarius Essentials membership; renewal cost is not shown on the store page	$4,490 (L15, L7, C3, PA, C7Vet) $6,090 (L20, PAL, EC7)
GE Vscan Air CLwireless, dual-head	Handheld, wireless	GE’s U.S. product page lists the price with a 3-year warranty; financing offered from $174/mo	Starting at $4,999 Third-party sources quote $4,995–$7,995 for other probe configurations and $2,500–$4,500 used
Suresult D3Ultra & CD2wireless	Handheld, wireless	FDA-certified; Suresult’s product pages list free software for iOS, Android and Windows with no subscription cost	$3,200 D3Ultra (list $5,500) $2,900 CD2 (list $3,700)

Every figure above was read from the manufacturer’s own U.S. pricing page, product page, or online store on July 25, 2026; the GE third-party range and used-unit range are attributed to third-party market sources, not to GE. This table is limited to the devices whose current U.S. price could be read from the maker’s own page on that date; it is not a list of every handheld on the market. More depth per brand lives in the device-by-device guides: Philips Lumify, Mindray, Clarius, Butterfly iQ3 and Sonosite iViz — and how the wider market prices, from handhelds to console systems, sits in the cost of ultrasound machine guide. Suresult’s sale prices reflect a promotion running at the time of access.

The same market, six years earlier

Price direction is easier to judge with a fixed reference point. In 2020, AAFP’s FPM practical guide reported that “entry-level ultrasound devices cost between $2,000 and $10,000,” and listed the examples below. Treat this strictly as a 2020 snapshot — several of these figures have since moved, and the Butterfly iQ on the list has since been replaced by newer generations — the iQ+ and iQ3 priced above.

All five figures as reported by Shen-Wagner and Deutchman, “Point-of-Care Ultrasound: A Practical Guide for Primary Care,” FPM 2020;27(6):33–40. Historical reference only — not current pricing.

What the price tag does not tell you

Two structural questions sit underneath the sticker. The first is software: the market genuinely splits between membership models and perpetual ones. Butterfly offers and prices membership tiers; Clarius bundles a first year of Essentials with the scanner; other makers, including Suresult, charge no recurring software fee. The second is regulatory vocabulary, which matters more than it looks. Diagnostic ultrasound systems reach the U.S. market through 510(k) clearance — a submission demonstrating the device is “as safe and effective, that is, substantially equivalent, to a legally marketed device.” Devices that clear this route are cleared, not approved; “approved” belongs to the premarket approval pathway. When GE’s Vscan launched in 2010 it was described as a prescription device cleared for abdominal, cardiac (adult and pediatric), urological, fetal and obstetric, pediatric, and thoracic or pleural applications; the Butterfly iQ’s October 2017 clearance covered 13 clinical applications, described at the time as the broadest clearance for a single ultrasound transducer. A seller who tells you an imaging device carries FDA “approval” is using the wrong word for the wrong pathway.

Which specific device suits a given clinic is a separate question with its own answer: the cross-brand performance comparison sits in the accuracy comparison, the budget path in the under-$3,000 guide, connectivity and battery behaviour in the wireless handheld hub, probe geometry in the probe types explainer, and five-year running costs in the total cost of ownership guide. This page stays on what POCUS is and how it is practiced.

No single national credential

POCUS training and certification: how clinicians learn, and what counts as qualified

There is no single national POCUS credential in the United States, and no body that issues a general licence to scan. What exists instead is a set of specialty positions, practice parameters, residency requirements, and voluntary certifications — which is why “is POCUS certification required?” has no yes-or-no answer. The honest answer is: it depends on your specialty, your hospital’s privileging committee, and what you intend to scan.

Numbers and quoted phrases from the source documents named in each row; full citations with access dates in Sources. ARDMS sits inside the Academy row rather than in a row of its own: the sources place it in the same non-profit Inteleos family and document no separate POCUS pathway under its name. Volume benchmarks are not the whole test: ACEP states directly that “additional assessment measures need to be utilized in addition to set number benchmarks” — standardized direct observation tools, OSCEs, quality-assurance image review, and simulation.

The certification question is genuinely unsettled — and both positions are on the record

ACEP’s conclusion is explicit: “Emergency US should be considered a core credential for emergency physicians undergoing privileging in modern healthcare systems without need for external certification.” The POCUS Certification Academy, meanwhile, sells external certifications and reports more than 150,000 clinicians certified. Both statements are accurate descriptions of their sources. They are positions, not a resolved standard, and the practical consequence is local: hospital privileging committees decide, and since 1999 the AMA’s Resolution HR 802 has recommended they do so by following specialty-specific guidelines.

For learning routes rather than credentials, the practical sequence is didactics, then scanning under review, then quality-assured independent practice. Structured courses with CME are compared in the online ultrasound courses roundup; for hands-on practice with a probe in your hand, the beginner MSK series walks through real scans step by step — elbow and Achilles, then shoulder, knee and foot, then nerve, ankle and fracture screening. Recorded scan output across applications sits in the scan video library, and more introductory guides are collected in POCUS basics and guides.

Where it stops working

Limitations, and when POCUS is not enough

A hub that only lists strengths is not useful at the bedside. Four limits show up repeatedly across the source documents, and every one of them is about the system around the probe rather than the probe itself.

Two further limits are worth naming plainly. Scope-of-practice friction is documented, not hypothetical: ACEP notes tension with exclusive imaging contracts that may be in place with consultative ultrasound practices, European radiology has published its own position on ultrasound imaging use, and the AMA resolution above exists precisely because credentialing was contested. And device-class realities are mundane but consequential — Cleveland Clinic lists battery dependency and the loss risk that comes with something small enough to pocket. On safety, ultrasound sits in a favourable position without being risk-free: no ionizing radiation, but the FDA’s exposure caution stands, and a diagnostic-ultrasound safety review written for POCUS practitioners exists for clinicians who want the physics in detail.

Where the real-world gap shows: documentation

This is the least glamorous limitation and the most common. A 2020 BMJ Open Quality study found POCUS documentation rates as low as 38% for some examinations, and the quality of internist POCUS reports has been formally audited in the literature. An undocumented scan still changed a decision — it just left no record that it did, which is a problem for the patient’s next clinician, for quality review, and for reimbursement.

When a POCUS device is not a good fit — and who should not buy one yet

If nobody in the practice has completed structured training, if there is no one to review images, and if there is no way to archive a study and put a report in the chart, then hardware is not the missing piece. Buy the training and build the review loop first; the probe is the cheap part of a POCUS program, and the sequence matters. The same applies to a single clinician hoping a handheld will substitute for a comprehensive study the patient actually needs — that is not what a focused exam does, and no device changes that. In both cases the honest recommendation is to keep your money until the program around the probe exists.

Getting paid, and keeping records

Billing and documentation basics

Reimbursement for POCUS is real but modest, and it is gated by documentation rather than by the scan. AAFP’s primary-care guide cites Medicare reimbursement for common POCUS codes in the range of $50 to $125 — useful for scale, dated to its 2020 publication, and dependent on payer, setting and code. What makes the difference between a billable study and an unbilled one is the record: ACEP’s guidelines state that ultrasound findings should be documented in the medical record with written reports available to the care team, and that digital archival with corresponding documentation is optimal and recommended.

Three practical consequences follow. First, image storage is part of the program, not an accessory — ACEP’s quality-assurance requirements name digital ultrasound management systems alongside physician direction and dedicated machines. Second, quality review is ongoing rather than one-off: the guidelines recommend continued quality assurance on 5–10% of exams after credentialing to document continued competency. Third, privileging is the gate that sits before either of those, decided locally, informed by specialty guidelines under the AMA’s 1999 resolution, and, in emergency medicine, by ABEM’s focused practice designation.

ACEP’s reimbursement FAQ and AAFP’s primary-care guide independently name the same three codes for focused exams of the kind described on this page: CPT 76705 — “ultrasound, abdominal, real-time with image documentation; limited (e.g., single organ, quadrant, follow-up)” in ACEP’s wording, the limited abdominal exam in AAFP’s; CPT 93308 — “echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up, or limited study,” AAFP’s limited echocardiography; and CPT 76604 — “ultrasound, chest (includes mediastinum), real-time with image documentation,” AAFP’s limited chest exam, which ACEP also applies to the thoracic component of an eFAST.

Both sources attach their conditions to the code rather than to the scan. ACEP states that “a stored image is mandatory to report CPT codes for all diagnostic and procedure guidance ultrasounds,” and that a physician billing the interpretation alone appends modifier -26. AAFP sets out what the independent report has to contain: two patient identifiers or demographics, the indication for the ultrasound, the adequacy of the scan, a description of the findings, and an interpretation. And the $50-to-$125 figure above is 2020 Medicare data from that same AAFP article rather than a current-year rate — codes, coverage and payment all turn on payer, setting and year.

Two boundary notes, stated once and meant: AIUM’s practice parameters describe minimum criteria for a complete examination and are “not intended to establish a legal standard of care,” and nothing on this page is billing or legal advice. Payer policies, state scope-of-practice rules and facility requirements may also apply, and they differ.

One standard for everyone

Methodology and disclosure

Commercial disclosure: Suresult manufactures two of the devices priced in this guide (the D3Ultra and the CD2) and this article is published on Suresult’s site. We handle that conflict the only honest way we know: this page ranks nothing and recommends no device, every current price — ours and every competitor’s — was read from that manufacturer’s own U.S. page on the same date, with the GE third-party ranges and the 2020 historical table labelled as exactly that, and every clinical claim is attributed to a medical society, federal agency, health system or peer-reviewed study that has nothing to do with any brand.

We wrote this page under three rules. Clinical claims are cited summaries with their original hedges intact: where a review said “may,” we kept “may,” and no accuracy figure is attached to any device, ours included — those numbers belong to the studies, the populations, and the operators that produced them. Prices were read from each manufacturer’s own U.S. pricing page, product page or store on July 25, 2026, with the single exception of the GE ranges attributed above to third-party market sources; the 2020 comparison table is labelled as historical throughout. Regulatory wording follows the FDA’s own distinction between 510(k) clearance and premarket approval.

One access note in the interest of reproducibility: ACEP’s 2023 guideline PDF on acep.org now redirects to member sign-in, so the full text was verified from an archived capture of that same official PDF, and the journal citation (Annals of Emergency Medicine 2023;82(3):e115–e155) is given in Sources alongside it. Where an earlier edition’s wording differs, the 2023 edition governs.

Quick answers

POCUS questions, answered